The clinical outcomes following rituximab (RTX) treatment in patients with systemic lupus erythematosus (SLE) is highly variable. We aimed to identify predictive and prognostic factors associated with RTX therapy outcomes in patients with SLE.
Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review / Pirone, Carmelo; Mendoza-Pinto, Claudia; van der Windt, Daniëlle A; Parker, Ben; O Sullivan, Miriam; Bruce, Ian N. - In: SEMINARS IN ARTHRITIS AND RHEUMATISM. - ISSN 1532-866X. - 47:3(2017), p. 384-396. [10.1016/j.semarthrit.2017.04.010]
Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review
Pirone, Carmelo;
2017
Abstract
The clinical outcomes following rituximab (RTX) treatment in patients with systemic lupus erythematosus (SLE) is highly variable. We aimed to identify predictive and prognostic factors associated with RTX therapy outcomes in patients with SLE.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pirone_Predictive_2017.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
523.65 kB
Formato
Adobe PDF
|
523.65 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
